Browse Category

NASDAQ:TGTX News 9 January 2026 - 11 January 2026

TG Therapeutics stock slid nearly 7% Friday — what to watch next week for TGTX

TG Therapeutics stock slid nearly 7% Friday — what to watch next week for TGTX

New York, Jan 10, 2026, 21:40 (ET) — Market closed. TG Therapeutics shares fell 6.6% on Friday to close at $28.47, down $2.03, as the biotech stock swung between $28.21 and $30.83 on about 3.3 million shares. The drop leaves traders heading into a big week for healthcare stocks as the J.P. Morgan Healthcare Conference opens Monday in San Francisco.…
TG Therapeutics (TGTX) stock drops 7% as JPMorgan healthcare conference nears — what investors watch next

TG Therapeutics (TGTX) stock drops 7% as JPMorgan healthcare conference nears — what investors watch next

New York, January 9, 2026, 15:59 (EST) — Regular session TG Therapeutics (TGTX.O) shares fell about 7% on Friday, reversing an early rise and leaving the biotech near its session low. The stock was down 7% at $28.35 by 3:55 p.m. EST after opening at $30.69 and sliding as low as $28.215. It hit $30.83 earlier in the session. The…

Stock Market Today

  • Balaji Phosphates' Stock Surges 11% Amid Strong Earnings Growth and Above-Industry ROE
    January 28, 2026, 9:05 PM EST. Balaji Phosphates Limited (NSE:BALAJIPHOS) shares rose 11% in the past week, driven by solid financial fundamentals. The company posted a return on equity (ROE) of 13% for the trailing twelve months ending September 2025, outperforming the industry average of 10%. ROE measures profitability relative to shareholder equity, and Balaji's higher-than-average figure signals efficient capital use. Additionally, the company achieved a 27% net income growth over five years, significantly above the industry's 8.8% average. While the ROE is modest, Balaji's impressive earnings growth suggests other factors like low dividend payout ratios or favorable market conditions might be at play. Investors should consider if earnings growth expectations are fully reflected in the current share price before making decisions.
Go toTop